Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jilin Dongfang Pharmaceutical is a Chinese pharmaceutical company based in Jilin City, specializing in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and modern chemical pharmaceuticals. The company's product portfolio primarily targets cardiovascular and cerebrovascular health, hepatology, and respiratory conditions. Key products include the Xinnao Shuantong Capsule and various treatments for chronic liver disease and digestive ailments. Jilin Dongfang operates large-scale manufacturing facilities compliant with Chinese GMP standards and serves the domestic healthcare market. The company is recognized as a high-tech enterprise within Jilin Province, emphasizing the modernization of traditional formulas. Its business model integrates scientific research with industrial production and commercial distribution across China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jilin Dongfang Pharmaceutical.